Committed to Innovative Cardiac Research


Home  |  About BCRT  |  Our Research  |  Our Publications  |  Heart Disease  |  Managing Heart Disease  |  Donate  |  Join Mailing List |  Contact Us

Our Research


Developing the field of Nuclear Cardiology for the detection of disease

Nuclear Cardiology is a branch of medical imaging which uses small amounts of radioactive substances for the diagnosis of heart disease. Nuclear Cardiology is an effective, non invasive way of detecting the extent of heart disease. Myocardial perfusion Imaging (MPI) scans provide a powerful and precise nuclear cardiology tool. Our Medical Director, Professor Avijit Lahiri is a pioneer in the research and development of Nuclear Cardiology techniques.

Dipyrimidole is often used during MPI scanning. Unfortunately, dipyrimidole has side effects. A new compound with fewer side effects has recently been developed by the pharmaceutical company CV Therapeutics. We are involved in a multi-centre study testing the efficacy of this drug as a safer alternative to dipyrimidole in MPI scans.

See Our Publications                                                                                       Back To Our Research

British Cardiac Research Trust

34, York St, London W1H 1FF, United Kingdom 

Site Map   |    Website Terms of Use and Privacy Policy

Registered U.K. Charity #: 1077234

Powered by KolWeb